266 related articles for article (PubMed ID: 31221190)
1. A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis.
Contarini G; Franceschini D; Facci L; Barbierato M; Giusti P; Zusso M
J Neuroinflammation; 2019 Jun; 16(1):126. PubMed ID: 31221190
[TBL] [Abstract][Full Text] [Related]
2. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S;
Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245
[TBL] [Abstract][Full Text] [Related]
3. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
Daru; 2015 Oct; 23():48. PubMed ID: 26489494
[TBL] [Abstract][Full Text] [Related]
4. Looking for a Treatment for the Early Stage of Alzheimer's Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin.
Facchinetti R; Valenza M; Bronzuoli MR; Menegoni G; Ratano P; Steardo L; Campolongo P; Scuderi C
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471239
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
[TBL] [Abstract][Full Text] [Related]
6. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
7. Co-Ultramicronized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte Precursor Cell Differentiation is Associated With Tyro3 Receptor Upregulation.
Facci L; Barbierato M; Fusco M; Giusti P; Zusso M
Front Pharmacol; 2021; 12():698133. PubMed ID: 34276381
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N
J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
[TBL] [Abstract][Full Text] [Related]
10. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
[TBL] [Abstract][Full Text] [Related]
12. Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells.
Barbierato M; Facci L; Marinelli C; Zusso M; Argentini C; Skaper SD; Giusti P
Sci Rep; 2015 Nov; 5():16676. PubMed ID: 26578323
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
Fontes LB; Dos Santos Dias D; de Carvalho LS; Mesquita HL; da Silva Reis L; Dias AT; Da Silva Filho AA; do Amaral Corrêa JO
J Pharm Pharmacol; 2014 Jun; 66(6):886-94. PubMed ID: 24447171
[TBL] [Abstract][Full Text] [Related]
15. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
Ludwig MD; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2018 Feb; 243(4):361-369. PubMed ID: 29307283
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
17. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.
Furlan R; Martino G; Galbiati F; Poliani PL; Smiroldo S; Bergami A; Desina G; Comi G; Flavell R; Su MS; Adorini L
J Immunol; 1999 Sep; 163(5):2403-9. PubMed ID: 10452974
[TBL] [Abstract][Full Text] [Related]
18. Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis.
Cruz-Herranz A; Dietrich M; Hilla AM; Yiu HH; Levin MH; Hecker C; Issberner A; Hallenberger A; Cordano C; Lehmann-Horn K; Balk LJ; Aktas O; Ingwersen J; von Gall C; Hartung HP; Zamvil SS; Fischer D; Albrecht P; Green AJ
J Neuroinflammation; 2019 Nov; 16(1):203. PubMed ID: 31684959
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
[TBL] [Abstract][Full Text] [Related]
20. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]